Nov 10 (Reuters) - Trillium Therapeutics Inc TRIL.TO
* Trillium Therapeutics reports third quarter 2017 financial and operating results
* Trillium Therapeutics Inc - Cash and marketable securities of $64.3 million at September 30, 2017
Nov 10 (Reuters) - Trillium Therapeutics Inc TRIL.TO
* Trillium Therapeutics reports third quarter 2017 financial and operating results
* Trillium Therapeutics Inc - Cash and marketable securities of $64.3 million at September 30, 2017